| 
			
			 The organoids - miniature functional cellular models of the human 
			placenta's earliest stages - will also allow researchers to explore 
			what makes a pregnancy healthy, and how certain diseases can pass 
			from a mother to a developing baby. 
 The human placenta supplies all the oxygen and nutrients essential 
			for growth of a foetus. If it fails to develop properly, pregnancy 
			can fail and end in stillbirth or miscarriage, or babies can be born 
			with developmental problems.
 
 Ashley Moffett, a professor at Cambridge University's pathology, 
			physiology, development and neuroscience department who co-led the 
			work, explained that while the placenta is absolutely essential for 
			supporting a baby as it grows inside the mother, researchers know 
			relatively little about it because of a lack of good experimental 
			models.
 
			
			 
			"It's the first organ that develops, yet it's also the least 
			understood," she told reporters at a briefing.
 
 The field of organoid science has blossomed in recent years, with 
			research teams growing everything from mini-brains to mini-livers to 
			mini-lungs and using them to gain greater understanding of human 
			biology and disease.
 
 DECADES OF RESEARCH
 
 The Cambridge team, whose latest work was published in the journal 
			Nature, began their efforts to grow human placental cells more than 
			30 years ago when Moffett and colleagues were studying cellular 
			events in the first few weeks of pregnancy.
 
 The team gradually developed ways to isolate and characterize 
			placental cells, and eventually found the right combination of 
			harvested cells and an organoid culture system to enable the 
			generation of mini placenta models.
 
			
            [to top of second column] | 
 
			"We've been trying to do this for years," Moffett said.
 Graham Burton, who also worked on this research, said the 
			mini-placenta success should also shed light on other 
			poorly-understood aspects of relationships between the placenta, the 
			uterus and the foetus. These include how the placenta prevents some 
			infections passing from the mother's blood to the baby, but fails to 
			stop others, such as the Zika virus, for example.
 
 The organoids may also be used for safety screening of drugs for 
			possible use in early pregnancy, and to deepen understanding of how 
			chromosomal abnormalities can disrupt normal development.
 
 Vivian Li, a specialist at Britain's Francis Crick Institute not 
			involved in this work, said it was an "exciting" step.
 
 "These mini-placentas are generated in small-scale, and certainly 
			cannot be used for making babies in a dish. But the ability to 
			culture (them) in the dish has opened up the possibilities for more 
			complex studies," she said in an emailed statement.
 
 (Reporting by Kate Kelland; Editing by Gareth Jones)
 
			[© 2018 Thomson Reuters. All rights 
				reserved.] Copyright 2018 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed.  
			Thompson Reuters is solely responsible for this content. 
			
			 |